Tenax Therapeutics Inc. held its 2025 annual meeting of stockholders on June 11, 2025. During the meeting, several proposals were voted upon. The stockholders elected June Almenoff, Michael Davidson, Declan Doogan, Christopher T. Giordano, Robyn M. Hunter, Gerald T. Proehl, and Stuart Rich to the Board of Directors. The Officer Exculpation Amendment was approved, adding provisions to the Certificate of Incorporation exculpating certain officers from liability in specific circumstances. However, the proposed amendments requiring all stockholder action to be taken at an annual or special meeting were not approved.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.